|
|||||
       |
(National Institutes of Health) A collaboration between Harvard University and innovation/crowdsourcing company InnoCentive generated nearly 200 ideas for new strategies to cure Type-1 diabetes, with the 12 winners announced yesterday by Harvard. The winners each received a $2,500 prize. The program was funded by an American Recovery and Reinvestment Act grant to Harvard . . . → Read More: Innovation Challenge Yields Type-1 Diabetes Ideas  2 comments - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, challenge, university (Ocean Power Technologies) Ocean Power Technologies (OPT) in Pennington, New Jersey, says it has completed the first-ever grid connection of a wave energy device in the United States at Marine Corps Base Hawaii on Oahu. The grid connection uses OPT’s PowerBuoy systems to produce what the company calls utility-grade, renewable energy that can . . . → Read More: First Wave Energy Device Connected to Power Grid 6 comments - (Comments are closed) Finance, New products, Regulations cleantech, DoD, energy, grant, standard The National Science Foundation Survey of Research and Development Expenditures at Universities and Colleges reports that private companies significantly increased their percentage of R&D spending on science and engineering at American universities in the government’s 2009 fiscal year. R&D spending at universities from all sources increased to $54.9 billion from 2008 to 2009, an increase . . . → Read More: Industry’s 2009 R&D Spending Rises at Universities (Agricultural Research Service) A soil scientist and engineer team at the USDA’s Agricultural Research Service (ARS) has found a way for dairy farmers to reduce ammonia emissions from their production facilities: injecting liquid manure into crop fields below the soil surface. A study conducted by soil scientist April Leytem and agricultural engineer David . . . → Read More: Technique Revealed to Curb Farm Ammonia Emissions Stem Cells (National Science Foundation) International Stem Cell Corporation (ISCO) in Oceanside, California, said today that its unfertilized egg collection and activation protocol have received the approval of an Institutional Review Board (IRB). IRB review and approval is a Federal requirement for studies with human subjects, and ensures to protect subjects from unnecessary . . . → Read More: Stem Cell Source Collection Gets Review Board OK The Korea Herald newspaper reports today that the Korean government plans to increase the budget for its Ministry of Knowledge Economy by 7 percent in 2011 to KRW 4.5 trillion (USD 3.9 billion), with most of the funds going to research and development that benefits sustainable economic growth. The plans released today show substantial increases . . . → Read More: Korea Boosts R&D Budget, Targets Economic Growth (Agricultural Research Service, USDA) Nestlé, the global food and health products company based in Switzerland, announced today the creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences to expand the company’s industrial presence in nutrition and wellness. Nestlé says the two new organizations — one an operating division and . . . → Read More: Nestlé to Open Health Science Subsidiary and Research Institute Two devices, mounted on the steering wheel of a driving simulator, convey navigation information — turn left or turn right — to the driver. (Nate Medeiros-Ward, University of Utah) A new study finds drivers talking on cell phones and not hearing spoken instructions from a passenger or navigation system, can still get directions . . . → Read More: Study: Tactile Signals Can Give Directions to Drivers Mycobacterium tuberculosis bacteria (CDC) A collaboration between the National Physical Laboratory (NPL), the U.K.’s national measurement institute in Teddington, England and Orla Protein Technologies, a biotech company in Newcastle upon Tyne, England has been awarded £91,000 ($US 144,000) by the U.K. Technology Strategy Board to investigate improved methods for the detection of tuberculosis . . . → Read More: U.K. Partnership to Research TB Testing Methods One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, grant Seattle Genetics Inc., a biotech company in Bothell, Washington, and and Millennium, a developer of cancer drugs in Cambridge, Massachusetts, today released positive top-line results from a trial of their drug brentuximab vedotin. The drug is antibody-drug conjugate that works like an antibody carrying molecules toxic to cancer cells, targeted to CD30, a marker for . . . → Read More: Trial Shows Positive Results for Hodgkin Lymphoma Drug One comment - (Comments are closed) New products, Regulations biotechnology, cancer, clinical trials, Europe, FDA, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.